Topiramate for migraine prophylaxis among Chinese population

被引:8
作者
Li, Ho Lun [1 ]
Kwan, Patrick
Leung, Howan
Yu, Evelyn
Tsoi, Tak Hong
Hui, Andrew Che Fai
Sheng, Bun
Lau, Kwok Kwong
机构
[1] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Div Neurol, Hong Kong, Hong Kong, Peoples R China
[3] Pamela Youde Nethersole Eastern Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源
HEADACHE | 2007年 / 47卷 / 04期
关键词
migraine; topiramate; Chinese; prophylaxis; PREVENTION;
D O I
10.1111/j.1526-4610.2007.00763_3.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We evaluated the efficacy and safety of topiramate for migraine prophylaxis among Chinese patients in a multicenter prospective observational study. We found that topiramate at low doses was effective in preventing migraine headache in Chinese patients and was generally well tolerated. There was no difference in baseline headache frequency or intensity between responders and nonresponders.
引用
收藏
页码:616 / 619
页数:4
相关论文
共 12 条
  • [1] Topiramate for migraine prevention - A randomized controlled trial
    Brandes, JL
    Saper, JR
    Diamond, M
    Couch, JR
    Lewis, DW
    Schmitt, J
    Neto, W
    Schwabe, S
    Jacobs, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (08): : 965 - 973
  • [2] Prevalence of migraine, tension-type headache, and other headaches in Hong Kong
    Cheung, RTF
    [J]. HEADACHE, 2000, 40 (06): : 473 - 479
  • [3] Topiramate improves health-related quality of life when used to prevent migraine
    Diamond, M
    Dahlöf, C
    Papadopoulos, G
    Neto, W
    Wu, SC
    [J]. HEADACHE, 2005, 45 (08): : 1023 - 1030
  • [4] Topiramate in migraine prophylaxis -: Results from a placebo-controlled trial with propranolol as an active control
    Diener, HC
    Tfelt-Hansen, P
    Dahlöf, C
    Láinez, MJA
    Sandrini, G
    Wang, SJ
    Neto, W
    Vijapurkar, U
    Doyle, A
    Jacobs, D
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 (08) : 943 - 950
  • [5] Lee BI, 1999, EPILEPSIA, V40, P1767
  • [6] The global burden of migraine: Measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF)
    Leonardi M.
    Steiner T.J.
    Scher A.T.
    Lipton R.B.
    [J]. The Journal of Headache and Pain, 2005, 6 (6) : 429 - 440
  • [7] LIM SH, 2001, NEURO J SE ASIA, V6, P121
  • [8] Topiramate in migraine prevention - Results of a large controlled trial
    Silberstein, SD
    Neto, W
    Schmitt, J
    Jacobs, D
    [J]. ARCHIVES OF NEUROLOGY, 2004, 61 (04) : 490 - 495
  • [9] Migraine pathophysiology and its clinical implications
    Silberstein, SD
    [J]. CEPHALALGIA, 2004, 24 : 2 - 7
  • [10] SILBERSTEIN SD, PRACTICE PARAMETER E